Bausch + Lomb

Santa Ana, Calif. – September 19, 2026 -- Robinson Pharma, Inc. (RPI) has received the "Above and Beyond" Supplier Award from Bausch + Lomb for September 2026, recognizing sustained operational performance following a $115 million infrastructure expansion.

Robinson Pharma completes $115 million facility expansion across Southern California

The contract manufacturer finalized a $75 million purchase of a 261,000-square-foot facility in Irvine near John Wayne Airport, adding to a prior $40.7 million acquisition in Santa Ana. The combined investments push Robinson Pharma's regional manufacturing footprint beyond one million square feet.

Company secures USP certification after clearing quality audits

Robinson Pharma achieved United States Pharmacopeia (USP) certification following the expansion, adding to its existing FDA, NSF GRMA, UL GMP, SQF, CCOF, and SCCI credentials.

Atlanta – September 15, 2026 -- Medication nonadherence costs the U.S. healthcare system as much as $300 billion annually, a gap Response Media is targeting with the launch of a new health and life sciences practice called RE:HEALTH.

Response Media debuts AdherenceIQ to predict patient drop-off before it happens

The agency introduced AdherenceIQ, a proprietary AI-powered behavioral intelligence platform designed to predict which patients will discontinue therapy and why. The tool combines behavioral science, privacy-compliant AI and advanced analytics to identify emotional and functional barriers to treatment, including concerns about side effects, necessity, distrust and stigma.